The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Actinic Keratosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class (Nucleoside metabolic inhibitor, NSAIDS, Immune response modifiers, Photoenhancers, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Actinic Keratosis Treatment Market will grow from USD 6.92 Billion in 2024 to USD 9.25 Billion by 2030 at a 4.95% CAGR. The global actinic keratosis (AK) treatment market encompasses pharma...
December 2025
185 pages
Anti-Hair Loss Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Product (shampoo & conditioner, oil, serum, others), Medicine), By Gender (Male, Female), By End user (Dermatology hospitals and clinics, Home Care Setting, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anti-Hair Loss Medicine Market, valued at USD 2.89 Billion in 2024, is projected to experience a CAGR of 8.55% to reach USD 4.73 Billion by 2030. The Global Anti-Hair Loss Medicine Market c...
December 2025
185 pages
Carbapenem Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (Urinary Tract Infections, Blood Stream Infections, Pneumonia, Intra-abdominal Infections, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Carbapenem Market, valued at USD 3.92 Billion in 2024, is projected to experience a CAGR of 4.85% to reach USD 5.21 Billion by 2030. Carbapenems are a critical class of broad-spectrum beta-...
December 2025
185 pages
Hyaluronidase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Animal Derived Hyaluronidase, Synthetic Hyaluronidase), By Application (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Hyaluronidase Market, valued at USD 1.11 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 1.85 Billion by 2030. Hyaluronidase is an enzyme that degrades hyaluronic a...
December 2025
180 pages
Protease Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease indication (HIV/AIDS, Hepatitis C, Alpha-1 Antitrypsin Deficiency, Hereditary Angioedema (HAE), Others), By End-Use (Hospitals & Clinics, Research Laboratories and Academic Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Protease Inhibitors Market, valued at USD 6.92 Billion in 2024, is projected to experience a CAGR of 4.76% to reach USD 9.15 Billion by 2030. Protease inhibitors constitute a class of thera...
December 2025
185 pages
Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Pantoprazole; Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole, Other), By Disease Allocation (Ulcers, Gastroesophageal Reflux Disease, Others), By Application (Hospitals, Clinic, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Proton Pump Inhibitors Market, valued at USD 3.15 Billion in 2024, is projected to experience a CAGR of 4.87% to reach USD 4.19 Billion by 2030. Proton Pump Inhibitors are a class of pharma...
December 2025
185 pages
Skin Hives Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Chronic Hives, Acute Hives), By Treatment (Anti-Inflammatory Drugs, Anti-Itch Drugs, Antihistamines, Others), By Route of Administration (Oral, Topical, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Skin Hives Treatment Market, valued at USD 2.98 Billion in 2024, is projected to experience a CAGR of 8.10% to reach USD 4.76 Billion by 2030. The Global Skin Hives Treatment Market compris...
December 2025
180 pages
Gastrointestinal Bleeding Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices), Closure Devices, Others), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End Users (Hospital/Clinics, Ambulatory Surgical Centres, Others), By Region, and By Competition, 2020-2030F
US$ 4,500.00
The Global Gastrointestinal Bleeding Treatment Market, valued at USD 562.44 Million in 2024, is projected to experience a CAGR of 5.88% to reach USD 792.34 Million by 2030. The Global Gastrointestinal...
December 2025
185 pages
Cystinuria treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Cystinuria Type 1, Cystinuria Type 2, Cystinuria Type 3), By Drugs (Tiopronin, Penicillamine, Captopril, Others), By Route of Administration (Oral, Injectables), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Cystinuria treatment Market, valued at USD 160.00 Million in 2024, is projected to experience a CAGR of 4.70% to reach USD 210.77 Million by 2030. The Global Cystinuria treatment market enc...
December 2025
180 pages
U.S. Plant-based API Market Size, Share & Trends Analysis Report By Molecule Type (Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin And Stilbenes), By End Use, And Segment Forecasts, 2025 - 2033
US$ 4,950.00
The U.S. plant-based API market size was estimated at USD 9.69 billion in 2024 and is projected to reach USD 15.77 billion by 2033, growing at a CAGR of 5.5% from 2025 to 2033. The market is witnessi...
December 2025
150 pages
Prophylactic HIV Drugs Market 2026
US$ 2,999.00
The Prophylactic HIV Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
December 2025
200 pages
Plant-based API Market Size, Share & Trends Analysis Report By Molecule Type (Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin and Stilbenes), By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global plant-based API market size was estimated at USD 31.78 billion in 2024 and is projected to reach USD 53.21 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is progr...
December 2025
150 pages
Drug Repurposing Market Forecasts to 2032 – Global Analysis By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune & Inflammatory Diseases, Rare Diseases, Metabolic Disorders, and Other Therapeutic Areas), Drug Type, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Drug Repurposing Market is accounted for $0.46 billion in 2025 and is expected to reach $1.40 billion by 2032 growing at a CAGR of 17.0% during the forecast pe...
November 2025
200 pages
Hormone-Balancing Therapeutics Market Forecasts to 2032 – Global Analysis By Hormone Type (Estrogen Modulators, Testosterone Regulators, Thyroid Hormone Therapies, Cortisol Balancing Drugs, Insulin & Metabolic Hormones and Peptide-Based Hormone Therapies), Formulation, Technology, Application, End User, and By Geography.
US$ 4,150.00
According to Stratistics MRC, the Global Hormone-Balancing Therapeutics Market is accounted for $23.6 billion in 2025 and is expected to reach $39.4 billion by 2032 growing at a CAGR of 7.6% during th...
November 2025
200 pages
Hyperkalemia Drugs Market Forecasts to 2032 – Global Analysis By Drug Type (Sodium Polystyrene Sulfonate (SPS), Patiromer, Sodium Zirconium Cyclosilicate, Calcium Polystyrene Sulfonate, and Other Drug Types), Route of Administration, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Hyperkalemia Drugs Market is accounted for $1.42 billion in 2025 and is expected to reach $3.97 billion by 2032 growing at a CAGR of 15.8% during the forecast...
November 2025
200 pages
Sinusitis Drugs Market Forecasts to 2032 – Global Analysis By Drug Class (Antibiotics, Combination Therapies, Intranasal Corticosteroids, Biologics & Monoclonal Antibodies, Oral Corticosteroids, Mucolytics & Expectorants, Antihistamines, Decongestants, Saline Solutions & Irrigation Products, and Other Drug Classes), Route of Administration, Disease Type, Prescription Type, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Sinusitis Drugs Market is accounted for $3.11 billion in 2025 and is expected to reach $4.96 billion by 2032 growing at a CAGR of 6.9% during the forecast peri...
November 2025
200 pages
Pharmaceutical Filtration: Global Markets
US$ 4,650.00
: The global market for pharmaceutical filtration is expected to grow from $12 billion in 2025 and is projected to reach $20.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of...
November 2025
152 pages
Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Molecule Type (Small Molecule, Large Molecule), By Synthesis (Biotech, Synthetic), By Drug Type (Innovative, Generics), By Workflow (Clinical, Commercial), By Application (Cardiology, Oncology, Ophthalmology, Neurology, Orthopedic, Other), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Active Pharmaceutical Ingredients CDMO Market, valued at USD 96.98 Million in 2024, is projected to experience a CAGR of 6.10% to reach USD 138.35 Million by 2030. An Active Pharmaceutical...
November 2025
185 pages
Albumin Excipient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Human Serum Albumin, Recombinant Albumin), By End user (Pharmaceutical And Biotechnology Industry, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Albumin Excipient Market, valued at USD 4.98 Billion in 2024, is projected to experience a CAGR of 8.01% to reach USD 7.91 Billion by 2030. Albumin excipient is a highly purified protein, t...
November 2025
187 pages
Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generic), By Drug Combination (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels), By Indications (Human Immunodeficiency Virus, Hepatitis, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Antiviral Combination Therapy Market, valued at USD 52.72 Billion in 2024, is projected to experience a CAGR of 6.85% to reach USD 78.46 Billion by 2030. Antiviral combination therapy invol...
November 2025
187 pages
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Anti-inflammatory, Combination Therapy, Bronchodilators), By Product (Inhalers (Dry powder inhalers, Metered dose inhalers, Soft mist inhalers), Nebulizers), By Route of Administration (Oral, Inhaled, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Asthma Therapeutics Market will grow from USD 27.52 Billion in 2024 to USD 34.3 Billion by 2030 at a 3.74% CAGR. Asthma therapeutics encompass a range of pharmaceutical medications and trea...
November 2025
185 pages
Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Cholinesterase Inhibitors, Chronic Immunomodulators, Monoclonal Antibodies, Rapid Immunotherapies, Thymectomy, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), Region and Competition, 2020-2030F
US$ 4,500.00
The Global Myasthenia Gravis Treatment Market, valued at USD 2.32 Billion in 2024, is projected to experience a CAGR of 7.44% to reach USD 3.57 Billion by 2030. Myasthenia Gravis treatment encompasses...
November 2025
185 pages
Softgel Capsules Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Gelatin-Based/Animal-Based, Non-Animal-Based), By Application (Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy, Others), End Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organization), By Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Softgel Capsules Market, valued at USD 8.02 Billion in 2024, is projected to experience a CAGR of 7.86% to reach USD 12.63 Billion by 2030. Softgel capsules represent a specialized oral dos...
November 2025
182 pages
Gout Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (NSAIDs, Colchicine, Urate-lowering Drugs, Biologics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition 2020-2030F
US$ 4,500.00
The Global Gout Therapeutics Market, valued at USD 2.16 Billion in 2024, is projected to experience a CAGR of 8.80% to reach USD 3.58 Billion by 2030. Gout therapeutics comprise pharmaceutical interve...
November 2025
180 pages
Hepatology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Antiviral Drugs, Vaccines, Immunosuppressants, Targeted Therapy, Chemotherapy, Corticosteroids, Immunoglobulins), By Disease Type (Hepatitis, Liver Cancer, Genetic Disorders, Autoimmune Diseases, Non- Alcoholic Fatty Liver Diseases, Others) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Hepatology Market, valued at USD 12.18 Billion in 2024, is projected to experience a CAGR of 8.60% to reach USD 19.98 Billion by 2030. The global hepatology market encompasses the study, pr...
November 2025
183 pages
Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas), By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations), By End User (Humans, Veterinary) By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encom...
November 2025
183 pages
Hemoglobinopathies Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Thalassemia, Sickle Cell Disease, Other Hemoglobin (Hb) Variants), By Diagnosis (Blood Test, Genetic Test, Prenatal Genetic Test, Pre-implantation Genetic Diagnosis, Electrophoresis, Others), By Therapy (Blood Transfusion, Iron Chelation Therapy, Hydroxyurea, Bone Marrow Transplant, Others), By Region, Competition, 2020-2030F
US$ 4,500.00
The Global Hemoglobinopathies Market , valued at USD 8.44 Billion in 2024, is projected to experience a CAGR of 12.70% to reach USD 17.29 Billion by 2030. Hemoglobinopathies represent a group of inher...
November 2025
180 pages
5HT3 Receptor Antagonists Market 2026
US$ 2,999.00
The 5HT3 Receptor Antagonists Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
200 pages
Achalasia Treatment Market 2026
US$ 2,999.00
The Achalasia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
218 pages
Acromegaly Treatment Market - 2022-2031
US$ 2,999.00
The Acromegaly Treatment Market was valued at US$ 1.2 billion in 2022 and is anticipated to reach US$ 2.1 billion by 2031, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth insights i...
November 2025
218 pages
Acute Intermittent Porphyria Market 2026
US$ 2,999.00
The Acute Intermittent Porphyria Market was valued at in and is anticipated to reach by , at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
243 pages
Adrenoleukodystrophy Treatment Market - 2023-2031
US$ 2,999.00
The Adrenoleukodystrophy Treatment Market was valued at US$ 323.36 million in 2023 and is anticipated to reach US$ 673.03 million by 2031, at a CAGR of 0.096 from 2026 to 2032. The report delivers in-...
November 2025
219 pages
Alcoholic Hepatitis Treatment Market 2026
US$ 2,999.00
The Alcoholic Hepatitis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
207 pages
Alpha-mannosidosis Treatment Market 2026
US$ 2,999.00
The Alpha-mannosidosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
207 pages
Ampicillin Market 2026
US$ 2,999.00
The Ampicillin Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
210 pages
Amyloidosis Treatment Market 2026
US$ 2,999.00
The Amyloidosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
217 pages
Anal Fissure Therapeutics Market 2026
US$ 2,999.00
The Anal Fissure Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
223 pages
Andersen-Tawil Syndrome Market 2026
US$ 2,999.00
The Andersen-Tawil Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of 0.034 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
223 pages
Androgens and Anabolic Steroids Market 2026
US$ 2,999.00
The Androgens and Anabolic Steroids Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
November 2025
223 pages
Antacids Market 2026
US$ 2,999.00
The Antacids Market was valued at in and is anticipated to reach by , at a CAGR of 0.031 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
243 pages
Anti-Diarrheal Drugs Market 2026
US$ 2,999.00
The Anti-Diarrheal Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
218 pages
Anti-Infective Drugs Market 2026
US$ 2,999.00
The Anti-Infective Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
218 pages
Anti-viral Therapeutics Market - 2021-2031
US$ 2,999.00
The Anti-viral Therapeutics Market was valued at US$ 51.72 billion in 2021 and is anticipated to reach US$ 70.83 billion by 2031, at a CAGR of 0.046 from 2026 to 2032. The report delivers in-depth ins...
November 2025
223 pages
Antibody-Mediated Rejection Market 2026
US$ 2,999.00
The Antibody-Mediated Rejection Market was valued at in and is anticipated to reach by , at a CAGR of 0.063 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
219 pages
Antifungal Drugs Market 2026
US$ 2,999.00
The Antifungal Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.033 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional g...
November 2025
219 pages
